Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
SGD Pharma
Sort By
Newest First
1 / 1
1 / 1
Appointment
SGD Pharma Announces the Appointment of Fabio Invernizzi, General Manager West Business Unit
SGD Pharma
PR-M01-24-02
January 17, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02
December 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01
December 14, 2023
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
June 24, 2022
Fill/Finish
Simplifying Operations with Ready-to-Use Vials
Alexander Bautista
SGD Pharma
PTV-06-21-CL-005
June 30, 2021
The Future of Healthcare
How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?
SGD
PAP-Q4-20-RT2-006
December 09, 2020
Glass Vials
SGD Pharma Extends Industry-Leading Ready-to-Use Molded Glass Vial Range With Introduction of EasyLyo and ISO20mm 50ml Sizes in Tray
SGD Pharma
PR-M09-20-33
September 30, 2020
The Future of Healthcare
How Is SGD Pharma Evolving its Business Model to Meet the Future of Healthcare?
SGD
PAP-Q3-20-RT2-002
September 29, 2020
The Future of Healthcare
How is SGD Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
SGD
PAP-Q2-20-RT2-008
July 01, 2020
The Future of Healthcare
How is SGD Pharma Preparing to Face the Future of Healthcare?
SGD
PAP-Q1-20-R2-003
March 19, 2020
Lyophilization
Alternative Vial Designs to Reduce Lyo-Breakage Risk
Kevin McLean
SGD Pharma
PAP-Q3-19-CL-027
October 28, 2019
RTU Glass
Implementing Ready-to-Use Glass Vials for Flexible Aseptic Filling
Carole Grassi
SGD Pharma
PAP-Q2-2019-CL-031
May 24, 2019
